Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Ashley Yegin · SciRah

Researcher profile · Semantic Scholar

Ashley Yegin

Share profile

Ashley Yegin — researcher profile on SciRah

h-index: 19
Works: 45
Citations: 1,577

Most-cited papers

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.
A. Antonini, W. Poewe, K. Chaudhuri, R. Jech +74 more
2017Parkinsonism & Related Disorders213 citations Open access
Semantic Scholar
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study
B. Chipps, Robert S. Zeiger, L. Borish, S. Wenzel +8 more
2012Journal of Allergy and Clinical Immunology208 citations Open access
Semantic Scholar
Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample
A. Quittner, G. Sawicki, A. Mcmullen, L. Rasouliyan +3 more
2012Quality of Life Research148 citations
Semantic Scholar
Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes.
A. Antonini, Ashley Yegin, Cornelia Preda, L. Bergmann +1 more
2015Parkinsonism & Related Disorders143 citations Open access
Semantic Scholar
RISK FACTORS FOR RATE OF DECLINE IN FEV1 IN ADULTS WITH CYSTIC FIBROSIS
M. Konstan, J. Wagener, D. VanDevanter, D. Pasta +3 more
2012Journal of Cystic Fibrosis111 citations Open access
Semantic Scholar
Clinical Use of Dornase Alfa Is Associated with a Slower Rate of FEV1 Decline in Cystic Fibrosis
M. Konstan, Jeffrey S. Wagener, D. J. Pasta, S. Millar +3 more
2011Pediatric Pulmonology94 citations Open access
Semantic Scholar
Cerebral Edema Associated With Large Hemispheric Infarction.
D. Liebeskind, E. Jüttler, Yu. V. Shapovalov, Ashley Yegin +2 more
2019Stroke87 citations Open access
Semantic Scholar
Erratum to: Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample
A. Quittner, G. Sawicki, A. Mcmullen, L. Rasouliyan +3 more
2012Quality of Life Research82 citations Open access
Semantic Scholar
Trends in the Use of Routine Therapies in Cystic Fibrosis: 1995–2005
M. Konstan, D. VanDevanter, L. Rasouliyan, D. J. Pasta +3 more
2010Pediatric Pulmonology63 citations Open access
Semantic Scholar
Severity of asthma score predicts clinical outcomes in patients with moderate to severe persistent asthma.
M. Eisner, Ashley Yegin, B. Trzaskoma
2012Chest57 citations
Semantic Scholar
Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.
R. Zeiger, Ashley Yegin, F. Simons, T. Haselkorn +3 more
2012Annals of Allergy, Asthma & Immunology51 citations
Semantic Scholar
Multiple Antibiotic–Resistant Pseudomonas aeruginosa and Lung Function Decline in Patients with Cystic Fibrosis
C. Ren, M. Konstan, Ashley Yegin, L. Rasouliyan +3 more
2012Journal of Cystic Fibrosis50 citations Open access
Semantic Scholar
DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING RATE OF FEV1 DECLINE AS AN EFFICACY ENDPOINT
M. Konstan, J. Wagener, Ashley Yegin, S. Millar +2 more
2010Journal of Cystic Fibrosis45 citations Open access
Semantic Scholar
Probability of Treatment Following Acute Drop in Lung Function in Children with Cystic Fibrosis is related to baseline pulmonary function
W. Morgan, J. Wagener, Ashley Yegin, D. Pasta +2 more
2013Jornal de Pediatria43 citations Open access
Semantic Scholar
Effects of omalizumab on changes in pulmonary function induced by controlled cat room challenge.
J. Corren, R. Wood, D. Patel, Jin Zhu +3 more
2011Journal of Allergy and Clinical Immunology38 citations
Semantic Scholar
DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING PULMONARY EXACERBATION AS AN EFFICACY ENDPOINT
D. VanDevanter, Ashley Yegin, W. Morgan, S. Millar +2 more
2011Journal of Cystic Fibrosis37 citations Open access
Semantic Scholar
An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease Patients
R. Krüger, P. Lingor, T. Doskas, J. Henselmans +8 more
2017Advances in Therapy29 citations Open access
Semantic Scholar
The role and structure of the multidisciplinary team in the management of advanced Parkinson’s disease with a focus on the use of levodopa–carbidopa intestinal gel
S. Pedersen, M. Suedmeyer, L. Liu, D. Domagk +5 more
2017Journal of Multidisciplinary Healthcare24 citations Open access
Semantic Scholar
Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson's disease.
A. Antonini, W. Robieson, L. Bergmann, Ashley Yegin +1 more
2018Neurodegenerative Disease Management19 citations Open access
Semantic Scholar
Current challenges and future opportunities in patient‐focused management of hereditary angioedema: A narrative review
A. Grumach, N. Gadir, A. Kessel, Ashley Yegin +2 more
2023Clinical and Translational Allergy16 citations Open access
Semantic Scholar
Concomitant Asthma Medication Use by Patients Receiving Omalizumab 2003–2008
M. Broder, J. Zazzali, E. Chang, Ashley Yegin
2011Journal of Asthma5 citations
Semantic Scholar
Impact of Omalizumab Treatment on Concomitant Asthma Medications in Patients With Moderate-to-Severe Allergic Asthma
Ashley Yegin, M. Eisner, B. Trzaskoma, Hubert C. Chen
20114 citations
Semantic Scholar
Effectiveness, Safety, and Patient-Reported Outcomes (PROs) in Patients With Hereditary Angioedema (HAE) From the United States and Canada Treated With Lanadelumab: 24-Month Data From the EMPOWER Study
H. Wedner, J. Bernstein, S. Betschel, M. Manning +6 more
2023Journal of Allergy and Clinical Immunology3 citations
Semantic Scholar
Global Long-term Registry on Efficacy and Safety of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease in Routine Care (GLORIA) - Interim Results in a Subgroup of Patients with Dyskinesia at Baseline (P1.192)
W. Poewe, K. Chaudhuri, L. Bergmann, Ashley Yegin +2 more
2015Neurology2 citations
Semantic Scholar
Global Long-Term Registry On Efficacy And Safety Of DUODOPA In Patients With Advanced Parkinson's Disease In Routine Care (GLORIA): 12-Month Interim Findings (S7.005)
A. Antonini, Ashley Yegin, Cornelia Preda, W. Poewe
2014Neurology2 citations
Semantic Scholar
Treatment patterns among patients with HAE-C1-INH: Interim analysis findings from US and Canada participants in the EMPOWER study
D. Goodyear, W. Lumry, John Anderson, R. Gagnon +6 more
2022Journal of Allergy and Clinical Immunology1 citations
Semantic Scholar
Baseline characteristics that influence “off” time improvement in levodopa-carbidopa intestinal gel-treated advanced Parkinson’s disease patients in the GLORIA registry
W. Poewe, L. Bergmann, Ashley Yegin, W. Robieson +1 more
20171 citations
Semantic Scholar
‘Advanced’ Parkinson’s disease characteristics in clinical practice: results from the OBSERVE-PD study, a cross-sectional observational study of 2615 patients (P6.001)
A. Fasano, L. Lopiano, B. Elibol, I. Smolentseva +7 more
2017Neurology1 citations
Semantic Scholar
Corrigendum to "Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes" [Parkinsonism Relat. Disord. 21(3) (2015) 231-235].
A. Antonini, Ashley Yegin, Cornelia Preda, L. Bergmann +1 more
2016Parkinsonism & Related Disorders1 citations Open access
Semantic Scholar
Global Long-Term Registry on Efficacy and Safety of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease in Routine Care (GLORIA) - Interim Results on Non-Motor Symptoms (I3-3B)
A. Antonini, K. Chaudhuri, Ashley Yegin, L. Bergmann +1 more
2015Neurology1 citations
Semantic Scholar
Evaluation of the Impairment Domain Components of the NHLBI Guidelines in Classifying Asthma Control and Predicting Future Asthma Exacerbations
R. Zeiger, Ashley Yegin, F. Simons, T. Haselkorn +3 more
20101 citations
Semantic Scholar
Severity of Asthma Score Prospectively Predicts Clinical Outcomes
M. Eisner, Ashley Yegin, B. Trzaskoma
20101 citations
Semantic Scholar
Lanadelumab efficacy and safety after switching from androgens: analysis of the phase 3 HELP and HELP OLE studies for hereditary angioedema
W. Lumry, D. Johnston, M. Riedl, Zia Choudhry +4 more
2022Journal of Allergy and Clinical Immunology0 citations
Semantic Scholar
Global long-term registry on efficacy and safety of levodopa-carbidopa intestinal gel in advanced Parkinson’s disease patients (GLORIA) – final results in a subgroup of patients with dyskinesia at baseline (S4.001)
W. Poewe, K. Chaudhuri, L. Bergmann, Ashley Yegin +2 more
2017Neurology0 citations
Semantic Scholar
Effect of levodopa-carbidopa intestinal gel on dyskinesia: design of an open-label, randomized multicenter 12-week study in advanced Parkinson’s disease patients (P1.024)
A. Antonini, W. Poewe, D. Standaert, C. Zadikoff +7 more
2017Neurology0 citations
Semantic Scholar
Effects of age and disease duration on quality of life outcomes in advanced Parkinson’s disease patients treated with levodopa-carbidopa intestinal gel infusions: a post-hoc analysis from the GLORIA registry (P1.028)
A. Antonini, W. Robieson, L. Bergmann, Ashley Yegin +1 more
2017Neurology0 citations
Semantic Scholar
Non-motor symptoms (nms) improvement is correlated with baseline nms burden and improved quality of life (QoL) in levodopa-carbidopa intestinal gel (LCIG) treated parkinson’s disease patients
K. Chaudhuri, W. Poewe, L. Bergmann, Ashley Yegin +1 more
20170 citations
Semantic Scholar
Levodopa-carbidopa intestinal gel treatment in patients with <10 years of Parkinson's disease: GLORIA registry interim results
A. Antonini, K. Chaudhuri, L. Bergmann, Ashley Yegin +2 more
20160 citations
Semantic Scholar
Gastrointestinal safety of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients: GLORIA long-term registry interim results
D. Domagk, S. Dam-Larsen, A. Antonini, L. Bergmann +2 more
20160 citations
Semantic Scholar
Global Long-Term Registry on Efficacy and Safety of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease in Routine Care (GLORIA) - Interim Results on Non-Motor Symptoms (P3.004)
A. Antonini, K. Chaudhuri, Ashley Yegin, L. Bergmann +1 more
2015Neurology0 citations
Semantic Scholar
Gastrointestinal Safety of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinsonʼs Disease Patients: Interim Results From the GLORIA Long-Term Registry: 1462
D. Domagk, S. Dam-Larsen, A. Antonini, L. Bergmann +2 more
20150 citations
Semantic Scholar
Lessons learned from the epidemiology and natural history of asthma: Outcomes and treatment regimens (TENOR)
B. Chipps, Ashley Yegin, L. Borish, S. Wenzel +8 more
2011European Respiratory Journal0 citations
Semantic Scholar
Association Between Severity of Asthma Exacerbations and Asthma-Related Quality of Life in Patients With Severe or Difficult-to-Treat Asthm
A. Luskin, Ashley Yegin, B. Chipps, L. Rasouliyan +2 more
20110 citations
Semantic Scholar
Rate Of Lung Function Decline As An Outcome For Randomized Controlled Trials In Cystic Fibrosis
M. Konstan, J. Wagener, Ashley Yegin, Stefanie J. Silva +2 more
2010Asian Test Symposium0 citations
Semantic Scholar
Relationship Between Decline In FEF25-75 And FEV1 In Cystic Fibrosis Patients 6-24 Years Old
W. Morgan, C. Ren, D. Pasta, Ashley Yegin +2 more
2010Asian Test Symposium0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Bergmann×11
Invite
L. Bergmann — researcher profile on SciRah
M. Konstan×11
Invite
M. Konstan — researcher profile on SciRah
A. Antonini×10
Invite
A. Antonini — researcher profile on SciRah
W. Poewe×9
Invite
W. Poewe — researcher profile on SciRah

×8

Invite

D. Pasta — researcher profile on SciRah

Invite

A. Antonini — researcher profile on SciRah

Invite

W. Poewe — researcher profile on SciRah

Invite

L. Bergmann — researcher profile on SciRah

Invite

Koray Onuk — researcher profile on SciRah

T. Haselkorn×5

Invite

T. Haselkorn — researcher profile on SciRah

L. Rasouliyan×5

Invite

L. Rasouliyan — researcher profile on SciRah

D. VanDevanter×5

Invite

D. VanDevanter — researcher profile on SciRah